Sildenafil, Singapore - Shim Clinic
Sildenafil is a phosphodiesterase type 5 (PDE5) inhibitor, which is used to treat erectile dysfunction. It is sold under the trade name Viagra® It is available in 100mg, 50mg, and 25mg.
It is used for erectile dysfunction treatment, when the person has erectile dysfunction.
Latest News
Female Viagra reemerges for as little as $25 a monthThu, 14 Jun 2018 05:24:52 +0800 | the Mail online | Health
The little pink pill that promises to improve women's libido is back and being sold online with a telemedicine prescription after it failed to generate enough excitement to become profitable in 2015. (Source: the Mail online | Health)
Controversy over return of female Viagra now online for just $25 a month
Thu, 14 Jun 2018 05:19:45 +0800 | the Mail online | Health
The little pink pill that promises to improve women's libido is back and being sold online with a telemedicine prescription after it failed to generate enough excitement to become profitable in 2015. (Source: the Mail online | Health)
Viagra and Nitrates Don't Mix
Wed, 13 Jun 2018 14:00:00 +0800 | MedicineNet Mens Health General
Title: Viagra and Nitrates Don't MixCategory: Doctor's& Expert's views on SymptomsCreated: 2/8/1999 12:00:00 AMLast Editorial Review: 6/13/2018 2:55:10 PM (Source: MedicineNet Mens Health General)
Viagra - Impotence Treatment Update
Wed, 13 Jun 2018 14:00:00 +0800 | MedicineNet Mens Health General
Title: Viagra - Impotence Treatment UpdateCategory: Doctor's& Expert's views on SymptomsCreated: 4/20/1998 12:00:00 AMLast Editorial Review: 6/13/2018 2:55:10 PM (Source: MedicineNet Mens Health General)
Viagra: The Little Blue Pill That Could
Wed, 13 Jun 2018 14:00:00 +0800 | MedicineNet Medications General
Title: Viagra: The Little Blue Pill That CouldCategory: Doctor's& Expert's views on SymptomsCreated: 6/16/2008 12:00:00 AMLast Editorial Review: 6/13/2018 2:55:10 PM (Source: MedicineNet Medications General)
Men With Erectile Dysfunction Are Twice As Likely to Have Heart Disease, Study Says
Mon, 11 Jun 2018 22:28:14 +0800 | TIME: Health
By now, most people are familiar with the factors that can increase the risk of having a heart attack: gaining too much weight, having high blood pressure or high cholesterol levels, smoking and not exercising enough. In a study published Monday in the journal Circulation, researchers say they have documented another risk factor that could help identify men at greatest risk of heart problems: Among a group of 1,900 men aged 60 to 78, those with erectile dysfunction were twice as likely as men without the condition to have a heart attack, stroke, or die of a heart problem. Around 20% of men over age 20 experience erectile dysfunction in the U.S., and the rates are higher among older men. The causes of the condition can vary and include stress-related psychological factors as well as physic...
Targeting Treatment of PH Due to Left Heart Disease Targeting Treatment of PH Due to Left Heart Disease
Thu, 07 Jun 2018 12:15:04 +0800 | Medscape Today Headlines
A new study indicates that treating PH-LHD with sildenafil is associated with worse clinical outcomes than placebo. How can this be explained?European Heart Journal (Source: Medscape Today Headlines)
Man says CVS worker told his wife about Viagra prescription
Wed, 06 Jun 2018 09:15:21 +0800 | ABC News: Health
A Long Island, New York, man alleges in a lawsuit that a CVS pharmacy worker told his wife about his prescription for erectile dysfunction medication and it ruined his marriage (Source: ABC News: Health)
Can Viagra help revive this biotech company?
Fri, 01 Jun 2018 04:28:27 +0800 | bizjournals.com Health Care:Biotechnology headlines
Drawing on more than $100 million to push its marquee drug into human clinical trials, Cleave Biosciences Inc. promised to open a new front in the war on cancer. Instead, following a clinical trial failure, Cleave’s CEO and all but a caretaker crew have departed, leaving the Burlingame company with two experimental drugs and little more than hope for a revival or a fire sale. Cleave’s story is common in biotech, where nearly nine of 10 drugs that ente r human testing fail to make it to market.… (Source: bizjournals.com Health Care:Biotechnology headlines)
Shoreside Enterprises Issues Voluntary Nationwide Recall of 7K and...
Fri, 25 May 2018 07:00:00 +0800 | PRWeb: Medical Pharmaceuticals
Shoreside Enterprises Issues Lot Specific Voluntary Nationwide Recall of 7K and Poseidon 4500 (Extreme 1000 mg) Due to Presence of Undeclared Sildenafil and Tadalafil(PRWeb May 25, 2018)Read the full story at http://www.prweb.com/releases/2018/05/prweb15518848.htm (Source: PRWeb: Medical Pharmaceuticals)
